Zafer Cantürk

738 total citations
17 papers, 260 citations indexed

About

Zafer Cantürk is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Zafer Cantürk has authored 17 papers receiving a total of 260 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Cancer Research and 6 papers in Surgery. Recurrent topics in Zafer Cantürk's work include Breast Cancer Treatment Studies (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Cancer Cells and Metastasis (3 papers). Zafer Cantürk is often cited by papers focused on Breast Cancer Treatment Studies (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Cancer Cells and Metastasis (3 papers). Zafer Cantürk collaborates with scholars based in Türkiye, United States and Belgium. Zafer Cantürk's co-authors include Ahmet Alponat, Patrick Pauwels, Marc Peeters, Naci Çine, Müge Serhatlı, Gizem Öner, Ahmet Tarık Baykal, Christophe Van Berckelaer, Sevilay Altıntaş and Hakan Savlı and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Zafer Cantürk

17 papers receiving 257 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zafer Cantürk Türkiye 9 105 102 90 87 41 17 260
Kaitao Yuan China 11 82 0.8× 70 0.7× 71 0.8× 84 1.0× 104 2.5× 20 424
Maria Maddalena Laterza Italy 10 192 1.8× 143 1.4× 81 0.9× 79 0.9× 59 1.4× 35 342
Baran Akagündüz Türkiye 9 141 1.3× 75 0.7× 39 0.4× 64 0.7× 42 1.0× 27 272
Christopher Hocking Australia 8 173 1.6× 186 1.8× 85 0.9× 86 1.0× 107 2.6× 16 334
Rafid Salim Jabir Malaysia 5 276 2.6× 87 0.9× 39 0.4× 93 1.1× 37 0.9× 7 349
Meizhi He China 8 120 1.1× 67 0.7× 71 0.8× 44 0.5× 100 2.4× 12 324
Chuan Huang China 10 76 0.7× 83 0.8× 43 0.5× 37 0.4× 93 2.3× 39 309
Xuanyi Du China 8 88 0.8× 108 1.1× 65 0.7× 48 0.6× 95 2.3× 17 356
Phani Keerthi Surapaneni United States 9 107 1.0× 85 0.8× 101 1.1× 156 1.8× 109 2.7× 27 364
Ying-Bo Chen China 15 126 1.2× 284 2.8× 151 1.7× 46 0.5× 43 1.0× 33 429

Countries citing papers authored by Zafer Cantürk

Since Specialization
Citations

This map shows the geographic impact of Zafer Cantürk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zafer Cantürk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zafer Cantürk more than expected).

Fields of papers citing papers by Zafer Cantürk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zafer Cantürk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zafer Cantürk. The network helps show where Zafer Cantürk may publish in the future.

Co-authorship network of co-authors of Zafer Cantürk

This figure shows the co-authorship network connecting the top 25 collaborators of Zafer Cantürk. A scholar is included among the top collaborators of Zafer Cantürk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zafer Cantürk. Zafer Cantürk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Öner, Gizem, Glenn Broeckx, Christophe Van Berckelaer, et al.. (2023). The immune microenvironment characterisation and dynamics in hormone receptor–positive breast cancer before and after neoadjuvant endocrine therapy. Cancer Medicine. 12(17). 17901–17913. 7 indexed citations
2.
Güler, Sertaç Ata, et al.. (2022). Vitamin and Micronutrient Deficiency and Peripheral Polyneuropathy Following Intragastric Balloon Technique Used For Obese People: Preliminary Study. Kocaeli Üniversitesi - AVESİS. 6(3). 208–214. 1 indexed citations
3.
Tarkun, İlhan, et al.. (2022). Comparison of the Effects of Exenatide and Insulin Glargine on Right and Left Ventricular Myocardial Deformation as Shown by 2D-Speckle-Tracking Echocardiograms. Nigerian Journal of Clinical Practice. 25(7). 1094–1101. 1 indexed citations
4.
Öner, Gizem, Sevilay Altıntaş, Zafer Cantürk, et al.. (2020). The immunologic aspects in hormone receptor positive breast cancer. Cancer Treatment and Research Communications. 25. 100207–100207. 11 indexed citations
5.
Soran, Atilla, Vahit Özmen, Serdar Özbaş, et al.. (2020). Abstract P1-20-01: Primary surgery in patients with de novo stage IV BC; finalizing the protocol MF07-01 randomized clinical trial. Cancer Research. 80(4_Supplement). P1–20. 2 indexed citations
6.
Soran, Atilla, Aykut Soyder, Serdar Özbaş, et al.. (2020). The role of loco-regional treatment in long-term quality of life in de novo stage IV breast cancer patients: protocol MF07-01Q. Supportive Care in Cancer. 29(7). 3823–3830. 11 indexed citations
7.
Öner, Gizem, Sevilay Altıntaş, Zafer Cantürk, et al.. (2019). Triple‐negative breast cancer—Role of immunology: A systemic review. The Breast Journal. 26(5). 995–999. 41 indexed citations
8.
Çabuk, Devrim, Turgay Şimşek, Gülçin Gacar, et al.. (2017). The distribution of CD44+/CD24- cancer stem cells in breast cancer and its relationship with prognostic factors.. PubMed. 21(5). 1121–1128. 6 indexed citations
9.
Ergül, Emel, et al.. (2016). TP53 (RS1042522) Polymorphism In Breast Cancer. SHILAP Revista de lepidopterología. 2(1). 28–31. 1 indexed citations
10.
Soran, Atilla, Vahit Özmen, Serdar Özbaş, et al.. (2016). A randomized controlled trial evaluating resection of the primary breast tumor in women presenting with de novo stage IV breast cancer: Turkish Study (Protocol MF07-01).. Journal of Clinical Oncology. 34(15_suppl). 1005–1005. 38 indexed citations
11.
Çine, Naci, et al.. (2014). Identification of ApoA1, HPX and POTEE genes by omic analysis in breast cancer. Oncology Reports. 32(3). 1078–1086. 38 indexed citations
12.
Aksu, Güzide, et al.. (2011). Correlation between c-erbB2 expression, lymphovascular invasion and other biological and clinical prognostic factors and preoperative tumor markers in patients with early-stage and locally advanced breast cancer.. PubMed. 16(1). 52–7. 4 indexed citations
13.
Topçu, Salih, Şerife Tuba Liman, Zafer Cantürk, et al.. (2008). Necessity for additional incisions with the cervical collar incision to remove retrosternal goiters. Surgery Today. 38(12). 1072–1077. 6 indexed citations
14.
Cantürk, Zafer, Ömer Şentürk, Nuh Zafer Cantürk, & Yonca Anık. (2008). Prevalence and risk fators for gall bladder polyps. East African Medical Journal. 84(7). 336–41. 20 indexed citations
15.
Alponat, Ahmet, et al.. (2002). Is minisite cholecystectomy less traumatic? Prospective randomized study comparing minisite and conventional laparoscopic cholecystectomies. World Journal of Surgery. 26(12). 1437–1440. 41 indexed citations
16.
Erçín, Cengiz, et al.. (2000). Imprint Cytology in the Diagnosis of <i>Helicobacter pylori</i>. Acta Cytologica. 44(2). 124–127. 8 indexed citations
17.
Cantürk, Zafer, et al.. (1998). Cytoprotective effects of alpha tocopherol against liver injury induced by extrahepatic biliary obstruction.. PubMed. 75(2). 77–80. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026